Back to Search
JANE DURKIN, D.O.
D.O.
Family Medicine Physician
NPI: 1740249663IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS006625L(PA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1987
Research & Publications (20)
The effects of lumbar massage on muscle fatigue, muscle oxygenation, low back discomfort, and driver performance during prolonged driving.
PMID 16393802·Ergonomics·2006
8-other
Body segment parameter estimation of the human lower leg using an elliptical model with validation from DEXA.
PMID 16847589·Ann Biomed Eng·2006
4-observational
Effects of minimum sampling rate and signal reconstruction on surface electromyographic signals.
PMID 15935959·J Electromyogr Kinesiol·2005
3-trial
Using mass distribution information to model the human thigh for body segment parameter estimation.
PMID 16060352·J Biomech Eng·2005
3-trial
Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loop.
PMID 15610029·Biochemistry·2004
7-preclinical
Analysis of body segment parameter differences between four human populations and the estimation errors of four popular mathematical models.
PMID 12968576·J Biomech Eng·2003
3-trial
The measurement of body segment inertial parameters using dual energy X-ray absorptiometry.
PMID 12445610·J Biomech·2002
4-observational
Cytoprotective effects of IAPs revealed by a small molecule antagonist.
PMID 18851715·Biochem J·2009
8-other
Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.
PMID 19237630·J Clin Oncol·2009
3-trial
ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitors.
PMID 19249873·Biochemistry·2009
7-preclinical
Implementation of a Morse potential to model hydroxyl behavior in phyllosilicates.
PMID 19355770·J Chem Phys·2009
8-other
Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.
PMID 18027851·Int J Cancer·2008
7-preclinical
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.
PMID 18570872·Mol Cell·2008
8-other
Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.
PMID 18714982·J Med Chem·2008
7-preclinical
The effect of ultrasound probe orientation on muscle architecture measurement.
PMID 16919969·J Electromyogr Kinesiol·2007
8-other
X-linked inhibitor of apoptosis regulates T cell effector function.
PMID 18025200·J Immunol·2007
7-preclinical
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
PMID 16804528·Br J Cancer·2006
4-observational
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
PMID 16951243·Clin Cancer Res·2006
7-preclinical
AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70.
PMID 16492569·Chem Biol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16 CHURCH ST
DALLAS, PA 18612 - Phone
- (570) 675-2111
Quick Facts
- NPI
- 1740249663
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile